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Abstract. The LC-UV, LC-MS and CE-UV study of chemical reaction between captopril and p-bromo- 
phenacyl bromide as derivatizing reagent is reported. During transformation of captopril, its thiol group  
is involved and the reaction is irreversible. Neutral or alkaline environments favor derivatization. The 
yield of reaction increases linear with the concentration of the reagent, while changes in temperature do 
not influence it significantly. Kinetic studies show that derivatization of captopril flows quickly, reaching 
a plateau after 30 minutes. Based on the study of these effects some important parameters such as deri- va-
tizing agent concentration, reaction time, temperature and pH were confined. The results were used  
for development of captopril determination methods both in pharmaceutical formulations and biological  
samples. (doi: 10.5562/cca1787)  
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INTRODUCTION 
Captopril (CAP) is an angiotensin converting enzyme 
inhibitor, used as antihypertensive agent. It is common 
that ACE inhibitors have low UV absorbtivity values 
and besides that captopril is very instable, undergoes to 
oxidation, the degradation product being the dimer.1 
Moreover, captopril also binds to endogenous com-
pounds (cysteine, glutathione). The mentioned proper-
ties make the determination of these drugs very diffi-
cult.2–4 To improve detection and to stabilize the com-
pound a derivatizing agent can be used. In our case  
the UV active agent was p-bromophenacyl bromide  
(p-BPB), which prevents captopril binding to plasma 
constituents and is also a chemical stabilizer.5–8 The 
resulted product can be determined at a more specific 
wavelength (λ = 260 nm). The possible reaction be-
tween the derivatizing agent and captopril involves the  
–SH group of the latter and the carbocation of the alkyl-
halide,9 resulting a derivative with greater molecular 
mass and less polarity (Figure 1). 
The aim of our study was to optimize several pa-
rameters of the derivatization reaction to get a good 
yield of transformation, to use these parameters in sam-
ple processing and to apply the derivatization in deter-
mination methods of captopril from biological matrices 
or pharmaceutical preparations. 
 
EXPERIMENTAL 
Materials and Methods 
All the reagents were of analytical or reagent grade 
purity. The derivatization reaction was followed by CE-
UV, LC-UV and LC-MS methods.  
Figure 1. The coupling reaction between CAP and p-BPB, 
resulting a Mr = 414 product. 
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For preliminary studies a low cost CE-UV method 
was developed: The instrument was an Agilent 6100 CE 
System, with an uncoated capillary (l = 38 cm, 50 µm 
i.d.). The temperature was set at 23 and 40 °C, buffer 
solution used KH2PO4 (c = 20 mmol dm
–3) + NaOH (c = 
0.1 mol dm–3), pH = 7.7. Polarity: positive, voltage: 20 
kV, Injection: pressure of 5 mbar applied during 5 s. UV 
detection was performed at 205 and 260 nm. 
For HPLC-UV studies the following assembly was 
used. The instrument was an Agilent 1100 series, chro-
matographic column was a Zorbax SB-C8 Solvent Saver 
Plus, l = 3×100 mm, 3.5 m i.d., the column temperature 
was set at 35 C. Mobile phase: phosphoric acid (c = 15 
mmol dm–3) in water-acetonitrile (w = 60–40 %), flow:  
1 mL min–1, with gradient elution as described in Table 1. 
The injection volume was 10 µL, the detector was 
set at 205 and 260 nm. 
For the LC-MS method, the liquid chromatograph 
was an Agilent 1200 series, equipped with a Chromolith 
Performance 100 × 4.6 mm, 3 µm i.d. column (Merck). 
The column temperature was set at 30 C. The mobile 
phase consisted in a mixture between A: formic acid 0.1 % 
in water; B: acetonitrile in isocratic elution A : B = 
60 : 40 %, flow 1 mL min–1. The injection volume was 
20 µL. The mass spectrometer, IonTrap SL 1100 series 
(Agilent), used an ionization source ESI+. The detection 
was in MRM mode, the monitored ions were 216, 253, 
255, 368, 370 m/z fragmented from 415 m/z parent ion 
of the derivative.  
Extraction of captopril from tablets: 20 tablets, 
each containing 25 mg captopril, were weighed and the 
average mass of one tablet was determined. A quantity 
of powder, corresponding to a content of 10 mg capto-
pril, was extracted with approximatelly 7 ml water in a 
10 mL volumetric flask in the ultrasonic bath (for 10 
minutes), then brought to volume with water and fil-
tered through the filter with the pore size of 0.45 µm. 
The resulted solution (γ = 1 mg mL–1) was diluted 20 
fold with water to reach the desired captopril concentra-
tion of 50 µg mL–1 (0.5 mL of initial captopril solution 
was dilluted with water in 10 mL volumetric flask). The 
derivatization reaction was performed as follows: 200 
µL from this sample was mixed with 20 µL 0.1 M KOH 
and 40 µL RD. After 15 minutes the mixture was neu-
tralized with 30 µL of 1 M HCl, then injected to HPLC.  
Sample preparation from plasma samples: Stan-
dard and test plasma samples were prepared as follows 
in order to be chromatographically analyzed. In an Ep-
pendorf tube 0.2 mL plasma with 40 L RD solution 
was vortex-mixed for 30 seconds. After 30 minutes, 
while the derivatization reaction was completed, the 
tube was shaken again for 30 seconds with 0.3 mL me-
thanol, and then centrifuged for 10 minutes at 14000 
rpm. The supernatant was transferred in an autosampler 
vial and 20 L were injected into the LC-MS system. 
RESULTS AND DISCUSSION 
The electrophoretic method was used only for prelimi-
nary studies, to observe whether the reaction occurs or 
not. Firstly the electropherograms of the two reactants 
(CAP and p-BPB) were recorded, then those of their 
mixture, at 30 minutes after mixing. This electrophero-
gram shows three peaks: the p-BPB being neutral mi-
grates together with EOF, captopril, being the most 
negatively charged, is the last that migrates. The third 
peak that appeared is the derivative’s one, which mi-
grates in front of captopril, being less negatively 
charged and more voluminous (Figure 2).  
Table 1. Gradient elution during HPLC-UV run 








Table 2. Calibration curves in analytical runs (peak area = 
a × c + b; n = 4 series) 
Series 10–4 a 10–4 b 
Determination 
coefficient R2 
CC1 2.40 –3.75 0.9990 
CC2 2.13 1.04 0.9987 
CC3 2.32 –2.34 0.9985 
CC4 2.18 3.10 0.9935 
Mean 2.26 –1.96 0.9974 
SD 0.12 3.12 0.0026 
 
Table 3. Accuracy (relative error of the found concentration) 
reported to the nominal and precision (variation coefficient) 
results, expressed in % 
 QCA QCB QCC QCD 
cnom. / µg mL
–1 24.0 28.0 50.00 80 
crec.1 / µg mL
–1 23.3 28.6 50.97 83 
crec.2 / µg mL
–1 23.8 28.7 50.91 84 
crec.3 / µg mL
–1 23.5 27.9 50.91 80 
Mean / µg mL–1 23.5 28.4 50.93 82.3 
SD 0.3 0.4 0.03 2.1 
CV / % 1.1 1.5 0.07 2.5 
Er / % 2.3 1.4 1.90 2.9 
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The presence of three peaks on the electrophero-
gram shows that the reaction occurs and the product 
(derivative) is formed.  
For further studies we switched to an HPLC-UV 
instrument, which gives better reproducibility for quan-
titative data and better determination of lower concen-
trations. With this method the parameters of derivatiza-
tion reaction were optimized. 
 
The Captopril: Derivatizing Agent Ratio 
The optimum molar ratio was found to be CAP : p-BPB 
= 1 : 1.4. 
 
The pH of the Reaction Medium 
The reaction is favored by alkaline medium but it also 
occurs with acceptable rate at neutral pH, which is im-
portant for plasma sample analysis (Figures 3 and 4). 
 
Reacting Time 
The time necessary for a complete transformation is 
about 30 minutes at neutral pH, in alkaline medium the 
reaction occurs instantaneously (3–5 minutes). 
 
Reaction Kinetics 
The kinetic profile of the derivatization reaction was 
recorded using 5 parallel determinations at the follow-
ing sampling times: 0.5, 1.0, 2.0, 4.0, 6.0, 8.0, 10.0, 
15.0, 20.0, and 30.0 minutes. 
The reaction order can be determined by the 
graphical method, plotting the peak area y / mAU min 
(which is proportional to the concentration of analyte) 
vs. time. The best fit to our data was achieved using a 
three parameter logarithmic function (Figure 5): 
 –  ×  ln(  + )y a b x c  
The obtained kinetic function was:  
 peak area = 639 + 539 ×  ln  + 0.3




Considering peak areamax / 2 = 2500 / 2 = 1250 mAU 
min, using the obtained equation, the half-life time can be 
calculated, being t1/2 = 2.8 min. This value is in good 
agreement with the experimental data (in approximately 
3 minutes the half of the initial quantity of captopril is 
derivatized). 
The reaction rate can be expressed as the inte-
grated form of the above equation, in our case:  
d















and the rate constant: k = b = 539 AU. 
Figure 3. Kinetic profile of the reaction at alkaline pH = 9–10
(achieved with NaOH or KOH, c = 1–100 mmol dm–3).  
Figure 2. The overlaid electropherograms of a blank sample 
(−−), captopril (- - -), p-BPB ( · · ·), and their mixture at 30 
minutes after mixing (- · - ) detected at λ = 205 nm. 
Figure 4. Kinetic profile of the reaction at neutral pH = 7.4
(achieved with ammonium formate or KH2PO4 + NaOH buffer).
 
Figure 5. Fitting function for reaction’s kinetic profile. 
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By HPLC-UV method a good separation of the de-
rivative was achieved even in the presence of plasma 
matrix constituents. The detection of the derivative at 
260 nm is much more selective than of captopril at 205 
nm (Figure 6). 
The detection limits calculated were minimum 1.0 
g mL–1 for underivatized Captopril at 205 nm, and 0.1 
g mL–1 in case of derivative, at 260 nm. So the speci-
ficity of wavelength allows 10 times lower detection 
limit for captopril as derivative (Figure 7). 
The developed HPLC-UV method is suitable for 
determination of captopril from pharmaceutical formu-
lations, e.g. tablets. Linearity of the method was verified 
in the 12–100 g mL–1 concentration range, with six ca-
libration standards, the results are presented in Table 2.  
The method has good accuracy and precision in 
the linearity range, Er and CV found to be below 3 % 
(Table 3). 
The captopril content from tablets (CCAT, expres-
sed in mg per tablet) is calculated using the sample 
concentration determined from the calibration curve (γcc, 
expressed in g mL–1), the average mass (mmean /g) of the 
20 tablets, the amount of sample taken (msample /g), and 









    
where γcc = 48.84 g mL–1; mmean = 0.14 g; msample = 
0.056 g (Figure 8). 
Substituting known values into the formula, the 
result is CCAT = 24.42 mg, which corresponds to official 
regulations, assay of content in tablets ± 7.5 %, which 
means that captopril content has to be in the range of 
23.125 – 26.875 mg. 
Taking in consideration the detection limits from 
HPLC-UV method, we can conclude that this method is 
still not suitable for bioequivalence and pharmacokinetic 
studies, where the plasma concentration of captopril is only 
of ng mL–1 (pg mL–1 injected to column) magnitude. This 
low-concentration problem can be solved by two ways:  
(i) Purification and concentration of samples by 
solid phase extraction (SPE) or liquid- liquid extraction 
(LL), but both are time consuming and very laborous. 
     
Figure 6. The chromatogram of the derivative (a) at λ = 260 nm and captopril (b) at λ = 205 nm. 
     
Figure 7. The S/N ratio in case of captopril (a) at λ = 205 nm, and derivative (b) at λ = 260 nm.  
(a) (b) 
(b) 
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(ii) Use of more sensitive, specific and efficient 
detection mode, like MS or MS/MS. 
The second way was considered being more effi-
cient, so for further experiments an LC-MS method was 
used. 
The MS/MS spectrum of the derivative is pre-
sented in Figure 9. The monitored ions were the MRM 
216, 253, 255, 368 and 370 m/z, fragmented from the 
parent ion 415 m/z. 
This HPLC-MS/MS method was able to quantify 
free captopril in human plasma after oral administration 
of a single dose of 100 mg captopril by applying a sim-
ple protein precipitation. Despite the sensitivity of the 
LC-MS/MS method, prior derivatization is needed in 
order to prevent captopril disulphide formation during 
sample processing and storage. The developed and vali-
dated method was used for bioequivalence investigation 
of two oral medicinal products containing captopril on a 
large number of human plasma samples. The results of 
the study were published previously by us.10 
 
CONCLUSIONS 
An LC-UV, LC-MS and CE-UV study of chemical reac-
tion between captopril and p-bromophenacyl bromide as 
derivatizing reagent was reported. During transformation 
of captopril, its thiol group is involved and the reaction is 
irreversible. The reaction occurs at room temperature in 
alkaline and neutral media as well, reaching a plateau 
after 30 minutes at neutral pH. The reaction follows a 
complex kinetic; the calculated half-life time (2.8 mi-
nutes) corresponds to the experimentally observed value. 
The optimized method of captopril determination was 
successfully applied to pharmaceutical formulations 
(HPLC-UV-25 mg tablets), and biological samples (bioe-
quivalence study, HPLC-MS human plasma). 
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Figure 8. Chromatogram of captopril solution extracted from 
tablets (final concentration 50 µg/mL)  
 
Figure 9. The MS/MS spectrum of the derivative. The moni-
tored ions were 216, 253, 255, 368, 370 m/z fragmented from 
415 m/z parent ion of the derivative.  
